Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Total Unconditional Purchase Obligations by Quarter
Total Unconditional Purchase Obligations ($M) ($M)
Natera Total Unconditional Purchase Obligations: $221M in Q2 2026, up 24.8% from a year earlier.
Where the Q2 2026 figure comes from
Source: Form 10-Q (2026-08-07) ↗
Total contractual non-cancelable purchase commitments across laboratory sequencing consumables, instruments, cloud computing, and clinical trial sample agreements ($189.20M at Q2 2026).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Unconditional Purchase Obligations ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 221 | +24.8% | Form 10-Q (2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 261 | +55.1% | Form 10-Q (2026-05-08) ↗ |
| Q4 2025 | Dec 31, 2025 | 257 | +50.0% | Form 10-K (2026-02-27) ↗ |
| Q3 2025 | Sep 30, 2025 | 158 | +56.5% | Form 10-Q (2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 177 | +70.7% | Form 10-Q (2025-08-08) ↗ |
| Q1 2025 | Mar 31, 2025 | 169 | +82.5% | Form 10-Q (2025-05-09) ↗ |
| Q4 2024 | Dec 31, 2024 | 171 | +81.2% | Form 10-K (2025-02-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 101 | +56.3% | Form 10-Q (2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 104 | +30.7% | Form 10-Q (2024-08-09) ↗ |
| Q1 2024 | Mar 31, 2024 | 92.4 | – | Form 10-Q (2024-05-10) ↗ |
| Q4 2023 | Dec 31, 2023 | 94.5 | +20.7% | Form 10-K (2024-02-29) ↗ |
| Q3 2023 | Sep 30, 2023 | 64.6 | -34.6% | Form 10-Q (2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 79.2 | -40.9% | Form 10-Q (2023-08-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 78.4 | -43.2% | Form 10-K (2023-03-01) ↗ |
| Q3 2022 | Sep 30, 2022 | 98.8 | +9.1% | Form 10-Q (2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 134 | +113.7% | Form 10-Q (2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 139 | +96.7% | Form 10-Q (2022-05-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 138 | +81.5% | Form 10-K (2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 90.6 | +124.7% | Form 10-Q (2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 62.7 | +73.1% | Form 10-Q (2021-08-06) ↗ |
| Q1 2021 | Mar 31, 2021 | 70.6 | +89.7% | Form 10-Q (2021-05-07) ↗ |
| Q4 2020 | Dec 31, 2020 | 76.0 | – | Form 10-K (2021-02-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 40.3 | – | Form 10-Q (2020-11-06) ↗ |
| Q2 2020 | Jun 30, 2020 | 36.2 | – | Form 10-Q (2020-08-07) ↗ |
| Q1 2020 | Mar 31, 2020 | 37.2 | – | Form 10-Q (2020-05-08) ↗ |
Breakdown
What makes up total Unconditional Purchase Obligations
- Inventory & Laboratory Sequencing Materials Purchase Obligations ($M)120 · Q2 2026
- Other Material Supplier Purchase Obligations ($M)48.3 · Q2 2026
- Application & IT Enterprise Services Purchase Obligations ($M)15.9 · Q2 2026
- Laboratory Sequencing Instruments & Equipment Purchase Obligations ($M)13.4 · Q2 2026
- Cloud Computing & Bioinformatics Infrastructure Purchase Obligations ($M)22.7 · Q2 2026
- Clinical Trial Samples & Registry Study Purchase Obligations ($M)1.30 · Q2 2026
- Software Development Services Purchase Obligations ($M) [legacy through Q1 2023]20.0 · Q1 2023
Cite this data
StockData. (2026). Natera Total Unconditional Purchase Obligations ($M), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/purchase-oblig-total
See every metric in the Natera KPI table. Data updated Nov 2, 2026.